AnticipatedClinical trial: Optional / allowed
Gilead Investigator-Sponsored Research — HIV
Gilead Sciences · Industry
Source: Gilead Sciences (curated) · View original posting ↗
Investigator-sponsored research (ISR) is accepted via Gilead's grant portal on a rolling/RFA basis — confirm current focus areas before applying.
- AwardWhat a single award can be worth — the funder's published per-award amount or floor–ceiling range.
- Amount not listed
- DeadlineFinal application due date.
- Not yet posted
- Letter of intentDue date for the letter of intent (a short pre-application some funders require or request before the full proposal).
- —
- MechanismNIH activity code — the grant type (R01 research project, R21 exploratory, K series career development, F series fellowship, …).
- —
- DurationMaximum project period for a single award.
- —
- Expected awardsHow many awards the funder anticipates making under this opportunity.
- —
- Funding cycleHow often the program accepts applications (annual, multiple cycles per year, rolling, or one-time).
- Rolling
- Open dateWhen applications open (or opened).
- —
- Total fundingThe overall pool the funder expects to commit across ALL awards under this opportunity — not what one project receives.
- —
- Clinical trialWhether proposed projects must, may, or must not include a clinical trial.
- Optional / allowed
Established investigatorHigher educationNonprofit
Research areas
Therapeutics & drug discoveryClinical trialsPrevention & risk factors
Auto-classified from the title and description (keyword-based) — may be imperfect.
Description
Industry support for investigator-initiated HIV research aligned with Gilead's therapeutic areas (treatment, prevention/PrEP, cure). Curated entry; verify current terms at the program page.
This funder has no public API, so the entry is manually curated — confirm current amounts, deadlines, and eligibility on the source page.